Research and Development

Showing 15 posts of 9596 posts found.

shutter

MSD and Eisai announce meaningful objective response rates for Keytruda+Lenvima combo in two cancer patient populations

May 29, 2020 Medical Communications, Research and Development Lenvima, keytruda, pharma

MSD has pulled back the curtain on new data from two trials of its anti-PD-1 immunotherapy Keytruda (pemvbrolizmuab) in combination …
martin_andrews

Evox appoints ex-GSK exec Martin Andrews as new non-Executive Director

May 28, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Evox, GSK, appointment

Evox Therapeutics has named ex-GlaxoSmithKline executive Martin Andrews as its new non-Executive Director, it has emerged.   Andrews has previously …
sergei_svarovsky

Axim Biotechnologies Inc announces Dr Sergei Svarovsky as Chief Scientific Officer of subsidiary Sapphire Biotech

May 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Axim Biotechnologies has announced that Dr Sergei Svarovsky will be the new Chief Scientific Officer of its subsidiary Sapphire Biotech. …
fda

FDA approves Sanofi’s Dupixent for children with dermatitis

May 27, 2020 Research and Development Dupixent, Sanofi, atopic eczema

The FDA has approved Sanofi’s Dupixent (dupilumab) for children between ages 6 to 11 with moderate to severe atopic dermatitis. …
cdc_coronavirus

Pharmafile.com’s weekly COVID-19 news round-up

May 27, 2020 Research and Development COVID-19, coronavirus, coronavirus round up

COVID-19 vaccines and treatments continue to dominate the news, as AstraZeneca is attempting to deliver one billion doses of coronavirus …

NICE reverses previous stance to recommend Roche’s Tecentriq in extensive-stage small-cell lung cancer

May 27, 2020 Research and Development, Sales and Marketing NICE, Roche, lung cancer, tecentriq

NHS patients with treatment-naïve extensive-stage small-cell lung cancer (ES-SCLC) in England and Wales will soon have access to a new …
nhsssssss

Remdesivir available to select COVID-19 patients through the NHS

May 27, 2020 Research and Development coronavirus, covid19

Gilead Sciences Ebola drug remdesivir will be available for selected patients who are suffering from coronavirus through the NHS. The …
darren_taylor1

Living with multiple ‘invisible’ conditions

May 26, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient experience, rare disease

Darren Taylor lives with a range of conditions including Dercum’s disease, cystic fibrosis, fibromyalgia with chronic fatigue, and Tietze syndrome, …
4223373030_df7722f9f7_c

Harvard study suggests monkeys develop immunity after receiving COVID-19 vaccines

May 21, 2020 Research and Development COVID-19, vaccine coronavirus

“The COVID-19 pandemic has made the development of a safe, effective, and deployable vaccine a critical global priority”, said researchers …
covid

Pharmafile.com’s weekly COVID-19 news round-up

May 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Trump, coronavirus

Trump continues to play a key role in the unfolding COVID-19 pandemic, with the US currently coping with the largest …
mit

MIT-developed algorithm seeks to accelerate drug approvals during COVID-19 pandemic

May 20, 2020 Research and Development, Sales and Marketing COVID-19, MIT, coronavirus, regulatory

A study emerging from the Massachusetts Institute of Technology (MIT) and published in the Harvard Data Science Review has detailed strategies …
ai

New research outlines guidelines for the ethical use of AI in healthcare

May 20, 2020 Research and Development AI, coronavirus

A new study published in The Lancet has called on the global health community to establish guidelines to develop and …

Nanotechnology could be used to assess mortality risk in COVID-19 patients

May 20, 2020 Research and Development COVID-19, coronavirus, nanotechnology

Doctors could use nanotechnology to assess the morality risk from COVID-19, according to research from Michigan State University. Morteza Mahmoudi, …
diabetes_3

Type 1 diabetics more likely to die from COVID-19 than type 2, according to the NHS

May 20, 2020 Research and Development COVID-19, Diabetics, coronavirus, diabetes

People suffering type 1 diabetes are far more likely to die of coronavirus than those with type 2, according to …
The Gateway to Local Adoption Series

Latest content